Dr White completed her MSc and PhD in pharmacology at the Institute of Psychiatry, University of London and has more than 15 years experience working in Europe in start-up biotechnology and pharmaceutical companies including Wyeth, Merck, Sharpe and Dohme and Cerebrus (now Vernalis plc).

Since returning to Australia in 1998, Dr White has held Senior Executive,  MD/CEO and Board positions in public and private biotechnology companies and Cooperative Research Centres.

Julie has extensive experience in managing start-up companies, commercialisation, negotiating and managing large complex multiparty ventures, establishing robust governance systems underpinning collaborative research programs.

Dr. White maintains a significant senior international executive network in the pharmaceutical and biotechnology industry expanding Asia, Europe and North America.